Literature DB >> 24813782

Nanocrystals of medium soluble actives--novel concept for improved dermal delivery and production strategy.

Xuezhen Zhai1, Jürgen Lademann2, Cornelia M Keck3, Rainer H Müller4.   

Abstract

After use in oral pharmaceutical products, nanocrystals are meanwhile applied to improve the dermal penetration of cosmetic actives (e.g. rutin, hesperidin) and of drugs. By now, nanocrystals are only dermally applied made from poorly soluble actives. The novel concept is to formulate nanocrystals also from medium soluble actives, and to apply a dermal formulation containing additionally nanocrystals. The nanocrystals should act as fast dissolving depot, increase saturation solubility and especially accumulate in the hair follicles, to further increase skin penetration. Caffeine was used as model compound with relevance to market products, and a particular process was developed for the production of caffeine nanocrystals to overcome the supersaturation related effect of crystal growth and fiber formation - typical with medium soluble compounds. It is based on low energy milling (pearl milling) in combination with low dielectric constant dispersion media (water-ethanol or ethanol-propylene glycol mixtures) and optimal stabilizers. Most successful was Carbopol(®) 981 (e.g. 20% caffeine in ethanol-propylene glycol 3:7 with 2% Carbopol, w/w). Nanocrystals with varied sizes can now be produced in a controlled process e.g. 660 nm (optimal for hair follicle accumulation) to 250 nm (optimal for fast dissolution). The short term test proved stability over 2 months of the present formulation being sufficient to perform in vivo testing of the novel concept.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Caffeine (PubChem CID: 2519); Dermal application; Ethanol (PubChem CID: 702); Hair follicle accumulation; High pressure homogenization; Nanocrystals; Pearl milling; Penetration enhancement; Propylene glycol (PubChem CID: 1030)

Mesh:

Substances:

Year:  2014        PMID: 24813782     DOI: 10.1016/j.ijpharm.2014.04.060

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

Review 1.  Emerging Technologies to Target Drug Delivery to the Skin - the Role of Crystals and Carrier-Based Systems in the Case Study of Dapsone.

Authors:  Gabriela Schneider-Rauber; Debora Fretes Argenta; Thiago Caon
Journal:  Pharm Res       Date:  2020-11-09       Impact factor: 4.200

2.  Enhanced Dermal Delivery of Flurbiprofen Nanosuspension Based Gel: Development and Ex Vivo Permeation, Pharmacokinetic Evaluations.

Authors:  Ayse Nur Oktay; Sibel Ilbasmis-Tamer; Orhan Uludag; Nevin Celebi
Journal:  Pharm Res       Date:  2021-06-04       Impact factor: 4.200

3.  Enhanced transdermal delivery of meloxicam by nanocrystals: Preparation, in vitro and in vivo evaluation.

Authors:  Qin Yu; Xiying Wu; Quangang Zhu; Wei Wu; Zhongjian Chen; Ye Li; Yi Lu
Journal:  Asian J Pharm Sci       Date:  2017-12-07       Impact factor: 6.598

Review 4.  Parenteral nanosuspensions: a brief review from solubility enhancement to more novel and specific applications.

Authors:  Eknath Ahire; Shreya Thakkar; Mahesh Darshanwad; Manju Misra
Journal:  Acta Pharm Sin B       Date:  2018-07-26       Impact factor: 11.413

5.  Localised and sustained intradermal delivery of methotrexate using nanocrystal-loaded microneedle arrays: Potential for enhanced treatment of psoriasis.

Authors:  Ismaiel A Tekko; Andi Dian Permana; Lalitkumar Vora; Taher Hatahet; Helen O McCarthy; Ryan F Donnelly
Journal:  Eur J Pharm Sci       Date:  2020-07-15       Impact factor: 4.384

6.  Fabrication of Capsaicin Loaded Nanocrystals: Physical Characterizations and In Vivo Evaluation.

Authors:  Barkat Ali Khan; Furqan Rashid; Muhammad Khalid Khan; Saad Saeed Alqahtani; Muhammad Hadi Sultan; Yosif Almoshari
Journal:  Pharmaceutics       Date:  2021-06-07       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.